Laporan Laba Rugi (TTM)
Laporan Laba Rugi LakeShore Biopharma Co., Ltd - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2021 03-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2025 03-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 257 | 503 | 574 | 633 | 698 | 687 | 658 | 561 | 544 | 573 | 615 |
| Change (%) | 95.69 | 14.07 | 10.34 | 10.25 | -1.54 | -4.25 | -14.78 | -2.97 | 5.39 | 7.24 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 60 | 121 | 136 | 147 | 159 | 153 | 137 | 112 | 108 | 187 | 108 |
| Change (%) | 103.60 | 12.30 | 7.89 | 8.01 | -3.52 | -10.73 | -18.30 | -3.88 | 74.28 | -42.48 | |
| % of Revenue | 23.21 | 24.15 | 23.78 | 23.25 | 22.78 | 22.32 | 20.81 | 19.95 | 19.76 | 32.67 | 17.53 |
| Gross Operating Profit | 197 | 381 | 437 | 486 | 539 | 534 | 521 | 449 | 437 | 386 | 507 |
| Change (%) | 93.30 | 14.63 | 11.11 | 10.93 | -0.95 | -2.39 | -13.85 | -2.75 | -11.57 | 31.38 | |
| % of Revenue | 76.79 | 75.85 | 76.22 | 76.75 | 77.22 | 77.68 | 79.19 | 80.05 | 80.24 | 67.33 | 82.47 |
| SG&A | 225 | 279 | 317 | 350 | 370 | 339 | 363 | 373 | 427 | 435 | 401 |
| Change (%) | 24.00 | 13.65 | 10.47 | 5.66 | -8.24 | 6.97 | 2.88 | 14.29 | 1.81 | -7.66 | |
| % of Revenue | 87.47 | 55.43 | 55.22 | 55.29 | 52.98 | 49.38 | 55.17 | 66.60 | 78.45 | 75.78 | 65.25 |
| R&D | 94 | 211 | 219 | 211 | 265 | 319 | 349 | 374 | 342 | 303 | 146 |
| Change (%) | 123.78 | 3.91 | -3.85 | 25.75 | 20.09 | 9.52 | 7.06 | -8.60 | -11.35 | -51.66 | |
| % of Revenue | 36.72 | 42.00 | 38.26 | 33.34 | 38.02 | 46.38 | 53.05 | 66.64 | 62.78 | 52.81 | 23.80 |
| OpEx | 383 | 617 | 677 | 714 | 795 | 818 | 855 | 866 | 882 | 932 | 665 |
| Change (%) | 61.11 | 9.68 | 5.49 | 11.43 | 2.84 | 4.59 | 1.18 | 1.95 | 5.56 | -28.66 | |
| % of Revenue | 148.96 | 122.64 | 117.92 | 112.74 | 113.95 | 119.02 | 130.01 | 154.35 | 162.19 | 162.45 | 108.06 |
| Operating Income | -126 | -114 | -103 | -81 | -97 | -131 | -197 | -305 | -338 | -358 | -50 |
| Change (%) | -9.51 | -9.70 | -21.57 | 20.71 | 34.27 | 51.07 | 54.34 | 11.01 | 5.83 | -86.16 | |
| % of Revenue | -48.96 | -22.64 | -17.92 | -12.74 | -13.95 | -19.02 | -30.01 | -54.35 | -62.19 | -62.45 | -8.06 |
| Interest Expense | -30 | -3 | -10 | -18 | -24 | -31 | -32 | -31 | -31 | -44 | -16 |
| Change (%) | -90.85 | 264.91 | 77.29 | 35.62 | 29.42 | 2.12 | -2.99 | 2.29 | 41.82 | -64.51 | |
| % of Revenue | -11.55 | -0.54 | -1.73 | -2.78 | -3.42 | -4.49 | -4.79 | -5.45 | -5.75 | -7.73 | -2.56 |
| Net Income | -208 | -237 | -236 | -210 | -236 | -283 | -299 | -375 | -363 | -433 | -100 |
| Change (%) | 13.54 | -0.42 | -10.99 | 12.40 | 20.22 | 5.46 | 25.37 | -3.08 | 19.33 | -76.93 | |
| % of Revenue | -81.10 | -47.06 | -41.08 | -33.14 | -33.78 | -41.25 | -45.43 | -66.84 | -66.76 | -75.59 | -16.26 |
Source: Capital IQ
